Changhoon Lee1, R Dayne Mayfield2, R Adron Harris2. 1. Waggoner Center for Alcohol and Addiction Research, Section of Neurobiology and Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas. Electronic address: changhoonlee@ucla.edu. 2. Waggoner Center for Alcohol and Addiction Research, Section of Neurobiology and Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas.
Abstract
BACKGROUND: Chronic alcohol exposure can change splice variant expression. The gamma-aminobutyric acid type B (GABAB) receptor undergoes splicing and is an alcoholism treatment target, but there is little information about splicing changes in this receptor in alcoholics. We studied GABAB receptor subunit 1 (GABAB1) splicing in alcoholic postmortem brains. METHODS: To maximize GABAB1 splice junction identification, we combined gene specific libraries with RNA-seq. Splice junctions and mapped reads were also found from intronic and intergenic regions. We compared GABAB1 splice junctions in prefrontal cortices from 14 alcoholic and 15 control subjects and introduced new strategies, reads per kilobase of splice junction model per million mapped reads and reads per kilobase of gene model per million mapped reads, for quantitating splice junction and gene expression. RESULTS: Novel splice junction detection indicated that the GABAB1 gene is at least two times longer than the previously reported gene length. GABAB1 exon and intron expression data showed low expression at the 5' end exons and exon grouping. This indicated that there are short splicing variants in addition to GABAB receptor subunit GABAB1a, the longest known major transcript. We found that chronic alcohol altered exon/intron expression and splice junction levels. Decreased expression of the gamma-aminobutyric acid binding site, a transmembrane domain and a microRNA binding site may decrease normal GABAB1 transcript population and thereby decrease normal signal transduction in alcoholics. CONCLUSIONS: We discovered novel, complex splicing of GABAB1 in human brain and showed that chronic alcohol produces additional splicing complexity.
BACKGROUND: Chronic alcohol exposure can change splice variant expression. The gamma-aminobutyric acid type B (GABAB) receptor undergoes splicing and is an alcoholism treatment target, but there is little information about splicing changes in this receptor in alcoholics. We studied GABAB receptor subunit 1 (GABAB1) splicing in alcoholic postmortem brains. METHODS: To maximize GABAB1 splice junction identification, we combined gene specific libraries with RNA-seq. Splice junctions and mapped reads were also found from intronic and intergenic regions. We compared GABAB1 splice junctions in prefrontal cortices from 14 alcoholic and 15 control subjects and introduced new strategies, reads per kilobase of splice junction model per million mapped reads and reads per kilobase of gene model per million mapped reads, for quantitating splice junction and gene expression. RESULTS: Novel splice junction detection indicated that the GABAB1 gene is at least two times longer than the previously reported gene length. GABAB1 exon and intron expression data showed low expression at the 5' end exons and exon grouping. This indicated that there are short splicing variants in addition to GABAB receptor subunit GABAB1a, the longest known major transcript. We found that chronic alcohol altered exon/intron expression and splice junction levels. Decreased expression of the gamma-aminobutyric acid binding site, a transmembrane domain and a microRNA binding site may decrease normal GABAB1 transcript population and thereby decrease normal signal transduction in alcoholics. CONCLUSIONS: We discovered novel, complex splicing of GABAB1 in human brain and showed that chronic alcohol produces additional splicing complexity.
Authors: Jianwen Liu; Joanne M Lewohl; R Adron Harris; Vishwanath R Iyer; Peter R Dodd; Patrick K Randall; R Dayne Mayfield Journal: Neuropsychopharmacology Date: 2005-11-02 Impact factor: 7.853
Authors: Traute Flatscher-Bader; Marcel van der Brug; John W Hwang; Peter A Gochee; Izuru Matsumoto; Shin-Ichi Niwa; Peter A Wilce Journal: J Neurochem Date: 2005-04 Impact factor: 5.372
Authors: S Isomoto; M Kaibara; Y Sakurai-Yamashita; Y Nagayama; Y Uezono; K Yano; K Taniyama Journal: Biochem Biophys Res Commun Date: 1998-12-09 Impact factor: 3.575
Authors: T Sander; D Ball; R Murray; J Patel; J Samochowiec; G Winterer; H Rommelspacher; L G Schmidt; E W Loh Journal: Alcohol Clin Exp Res Date: 1999-03 Impact factor: 3.455
Authors: B Mosley; M P Beckmann; C J March; R L Idzerda; S D Gimpel; T VandenBos; D Friend; A Alpert; D Anderson; J Jackson Journal: Cell Date: 1989-10-20 Impact factor: 41.582
Authors: Elena O Gracheva; Julio F Cordero-Morales; José A González-Carcacía; Nicholas T Ingolia; Carlo Manno; Carla I Aranguren; Jonathan S Weissman; David Julius Journal: Nature Date: 2011-08-03 Impact factor: 49.962
Authors: Ovidiu D Iancu; Alexander Colville; Nicole A R Walter; Priscila Darakjian; Denesa L Oberbeck; James B Daunais; Christina L Zheng; Robert P Searles; Shannon K McWeeney; Kathleen A Grant; Robert Hitzemann Journal: Addict Biol Date: 2017-02-28 Impact factor: 4.280
Authors: A M Colville; O D Iancu; D L Oberbeck; P Darakjian; C L Zheng; N A R Walter; C A Harrington; R P Searles; S McWeeney; R J Hitzemann Journal: Genes Brain Behav Date: 2017-02-09 Impact factor: 3.449